Australia’s Pharma Regulator Suppressed Troubling Report about Pfizer COVID-19 Vaccine

https://twitter.com/AsherPress/status/1640518304107315201?s=20
Australia’s Pharma Regulator Suppressed Troubling Report about Pfizer COVID-19 Vaccine.
Australia’s Pharma Regulator Allowed Pfizer to Dictate Risk to Benefit Analysis: Suppressed Troubling Pfizer COVID Vaccine Report.

-Assessed No Long-Term Animal Studies:
Pfizer Indicated that Long-Term Immunity Would be Addressed by Human Data
02.22.2021

Recently, Australia’s Therapeutic Goods Administration (TGA) made a report from 2021 available to the public. Titled “Nonclinical Evaluation Report BNT162b2 [mRNA] COVID-19 Vaccine (COMIRNATYTM)” the document provides inputs from the preclinical work involving the Pfizer-BioNTech mRNA vaccine BNT162b2 (Comirnaty) via Pfizer Australia pty Ltd.

A bombshell actually, the TGA, the agency that is supposed to “safeguard and enhance the health of the Australian community through effective and timely regulation of therapeutic goods” seemingly let the pharmaceutical company in this case dictate the risk-benefit analysis. At the height of the pandemic and the onset of the mass COVID-19 vaccination rollout starting February 22, 2021, the data in this document wasn’t shared with the public.